Filing Details
- Accession Number:
- 0001209191-22-029092
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-05-16 14:14:55
- Reporting Period:
- 2022-05-12
- Accepted Time:
- 2022-05-16 14:14:55
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1703057 | Abcellera Biologics Inc. | ABCL | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1834449 | Ltd. Holdings Thermopylae | 2215 Yukon Street Vancouver A1 | No | No | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Shares | Acquisiton | 2022-05-12 | 1,408,468 | $6.41 | 55,215,758 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- The price reported in Column 4 is a weighted-average price. These shares were acquired in multiple transactions at prices ranging from $5.44 to $6.78. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each separate price within the range set forth in this footnote.
Billionaire Hedge Funds
